Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients

Tredese, F.; Maggino, T.; Salvagno, L.; Marchesoni, D.; Chizzolini, M.; Pattaro, R.F.

European Journal of Gynaecological Oncology 6(2): 136-138

1985


ISSN/ISBN: 0392-2936
PMID: 4029198
Document Number: 262257
A comparison between plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients has been performed. The LBSA level appears more specific then the CEA, especially for ovarian cancer. This finding has promoted a longitudinal study to show if LBSA test may prove a reliable marker of disease in ovarian cancer patients.

Document emailed within 1 workday
Secure & encrypted payments